|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2600 EUR | -0.19% |
|
-3.70% | -22.85% |
| Market Cap | 134M 153M 124M 114M 215M 14.74B 218M 1.48B 579M 7.21B 573M 561M 24.91B | P/E 2026 * |
-17.3x | P/E 2027 * | -4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.83M 2.09M 1.7M 1.56M 2.94M 201M 2.98M 20.21M 7.91M 98.46M 7.83M 7.66M 340M | EV / Sales 2026 * |
0.08x | EV / Sales 2027 * | 20.9x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.19% | ||
| 1 week | -3.70% | ||
| Current month | +9.94% | ||
| 1 month | +5.91% | ||
| 3 months | -31.85% | ||
| 6 months | -12.75% | ||
| Current year | -22.85% |
| 1 week | 0.25 |  | 0.27 |
| 1 month | 0.22 | | 0.28 |
| Current year | 0.22 | | 0.81 |
| 1 year | 0.22 | | 0.81 |
| 3 years | 0.15 | | 1.04 |
| 5 years | 0.15 | | 2.29 |
| 10 years | 0.15 | | 7.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 2026-05-31 |
Laurene Danon
DFI | Director of Finance/CFO | - | 2024-06-25 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2015-03-08 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 2023-03-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/6/26 | Redmile Biopharma Investments III LP
| Buy | Company | 18,928,571 | 6.2956% | |
| 1/31/26 | Sofinnova Partners SAS
| Buy | Company | 10,714,285 | 3.5636% | |
| 4/18/24 | Redmile Biopharma Investments III LP
| Buy | Company | 2,781,914 | 1.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | -3.70% | -16.13% | -20.85% | 153M | |
| -4.89% | -7.74% | -3.35% | +9.27% | 48.5B | |
| -0.14% | -0.76% | +378.26% | +583.71% | 38.97B | |
| +0.39% | +2.79% | +8.23% | +61.99% | 35.43B | |
| -1.54% | -4.01% | +5.95% | -13.03% | 33.65B | |
| -0.87% | -3.19% | -1.27% | +29.16% | 26.58B | |
| -1.28% | -6.20% | - | - | 16.82B | |
| -0.67% | -0.21% | +10.55% | +115.31% | 15.18B | |
| +1.32% | +1.85% | +11.40% | +15.52% | 13.89B | |
| +0.40% | -2.79% | +3.58% | -31.98% | 12.76B | |
| Average | -0.75% | -1.95% | +44.13% | +83.23% | 24.19B | |
| Weighted average by Cap. | -1.29% | -1.77% | +68.39% | +121.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.86M 24.95M 20.29M 18.65M 35.14M 2.41B 35.65M 242M 94.61M 1.18B 93.65M 91.63M 4.07B | 6.4M 7.3M 5.94M 5.46M 10.28M 704M 10.43M 70.72M 27.68M 345M 27.4M 26.81M 1.19B |
| Net income | -4.34M -4.95M -4.03M -3.7M -6.98M -478M -7.08M -48M -18.79M -234M -18.59M -18.19M -808M | -50.64M -57.8M -47.01M -43.2M -81.4M -5.58B -82.6M -560M -219M -2.73B -217M -212M -9.43B |
| Net Debt | -132M -151M -123M -113M -212M -14.54B -215M -1.46B -571M -7.11B -566M -553M -24.57B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | €0.2600 | -0.19% | 494,468 |
| 26-07-21 | €0.2605 | +5.25% | 572,499 |
| 26-07-20 | €0.2475 | -4.81% | 483,614 |
| 26-07-17 | €0.2600 | -3.35% | 656,834 |
| 26-07-16 | €0.2690 | -0.37% | 1,112,350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
Select your edition
All financial news and data tailored to specific country editions
